Skip to main content
. Author manuscript; available in PMC: 2016 Jun 15.
Published in final edited form as: Pharmacotherapy. 2009 Jul;29(7):775–783. doi: 10.1592/phco.29.7.775

Table 2.

Drug Therapy

No. (%) of Patients
Drug Acute MI
Cases
(n=2316)
Controls
(n=9700)
Concomitant antidiabetic drugs
 First-generation sulfonylurea 11 (0.5) 28 (0.3)
 Nonsulfonylurea secretagog 138 (6.0) 560 (5.8)
 α-Glucosidase inhibitor 65 (2.8) 223 (2.3)
Cardiovascular drugs
 Cholesterol-lowering drug 1329 (57.4) 4902 (50.5)
 Diuretic 1301 (56.2) 5183 (53.4)
 β-Blocker 1060 (45.8) 3519 (36.3)
 ACE inhibitor or ARB 1717 (74.1) 6771 (69.8)
 Calcium channel blocker 1029 (44.4) 3950 (40.7)
 Nitrate 979 (42.3) 2850 (29.4)
 α-Blocker 131 (5.7) 567 (5.9)
 Antiplatelet drug 1202 (51.9) 4393 (45.3)
 Digoxin 395 (17.1) 1400 (14.4)
 Antiarrhythmic 20 (0.9) 130 (1.3)
Psychotropic drugs
 Benzodiazepine 493 (21.3) 2251 (23.2)
 Nonbenzodiazepine
  hypnotic
340 (14.7) 1510 (15.6)
 Anticonvulsant 376 (16.2) 1919 (19.8)
 Opiate 1028 (44.4) 4610 (47.5)
 Atypical antipsychotic 216 (9.3) 1368 (14.1)
 Antidepressant 866 (37.4) 4045 (41.7)
Other drugs
 Antibiotic 1629 (70.3) 7022 (72.4)
 Corticosteroid 290 (12.5) 1450 (15.0)
 Selective estrogen receptor
  modulatora
48 (2.1) 250 (2.6)
 Hormone replacementa 184 (7.9) 1007 (10.4)

MI = myocardial infarction; ACE = angiotensin-converting enzyme; ARB = angiotensin II receptor blocker.

a

Estimated among men and women.